{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:45:42Z","timestamp":1768733142203,"version":"3.49.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1097\/md.0000000000010075","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T20:51:13Z","timestamp":1520369473000},"page":"e0075","source":"Crossref","is-referenced-by-count":18,"title":["The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease"],"prefix":"10.1097","volume":"97","author":[{"given":"Hong-Yu","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"We Nian","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cpcardiol.2011.08.002","article-title":"Pulmonary arterial hypertension","volume":"36","author":"Mclaughlin","year":"2011","journal-title":"Curr Probl Cardiol"},{"key":"R2-13-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.chest.2016.03.031","article-title":"Efficacy and safety of PAH-specific therapy in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials","volume":"150","author":"Liu","year":"2016","journal-title":"Chest"},{"key":"R3-13-20210226","first-page":"328","article-title":"Pulmonary arterial hypertension associated with congenital heart disease","volume":"21","author":"Zuckerman","year":"2012","journal-title":"Curr Pediatrics Rep"},{"key":"R4-13-20210226","first-page":"507","article-title":"Insight into pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD): classification and pharmacological management from a pediatric cardiological point of view","volume":"31","author":"Chen","year":"2015","journal-title":"Zhonghua Minguo Xin Zang Xue Hui Za Zhi"},{"key":"R5-13-20210226","first-page":"8","article-title":"Pulmonary arterial hypertension in congenital heart diseases C. Seminars in respiratory and critical care medicine.","volume":"421-","author":"Beghetti","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"R6-13-20210226","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2010.06.010","article-title":"Medical therapy for pediatric pulmonary arterial hypertension","volume":"157","author":"Tissot","year":"2010","journal-title":"J Pediatrics"},{"key":"R7-13-20210226","doi-asserted-by":"crossref","first-page":"840A","DOI":"10.1378\/chest.10295","article-title":"Safety and efficacy of bosentan in combination with sildenafil in PAH patients who experience inadequate clinical response to monotherapy: The COMPASS-3 Study","volume":"138","author":"Benza","year":"2010","journal-title":"Chest"},{"key":"R8-13-20210226","first-page":"S612","article-title":"Abstract 2264: long term effects of bosentan therapy on echocardiographic parameters in patients with Eisenmenger syndrome","volume":"120","author":"Kaya","year":"2009","journal-title":"Circulation"},{"key":"R9-13-20210226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0828-282X(09)70041-8","article-title":"Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review","volume":"25","author":"Fine","year":"2009","journal-title":"Can J Cardiol"},{"key":"R10-13-20210226","first-page":"e1","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"Epidemiol Biostat Pub Health"},{"key":"R11-13-20210226","first-page":"S38","article-title":"Cochrane handbook for systematic reviews of interventions","volume":"5","author":"Higgins","year":"2008","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie Pharmakologie"},{"key":"R12-13-20210226","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomized trails","volume":"343","author":"Higgins","year":"2011","journal-title":"Br Med J"},{"key":"R13-13-20210226","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"R14-13-20210226","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R15-13-20210226","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"R16-13-20210226","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12471-016-0820-z","article-title":"Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome","volume":"24","author":"van Riel","year":"2016","journal-title":"Netherlands Heart J"},{"key":"R17-13-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1155\/2006\/746176","article-title":"An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease","volume":"13","author":"Ibrahim","year":"2016","journal-title":"Can Respir J"},{"key":"R18-13-20210226","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","article-title":"Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study","volume":"93","author":"Apostolopoulou","year":"2007","journal-title":"Heart"},{"key":"R19-13-20210226","first-page":"e7","article-title":"Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy","volume":"150","author":"Schulzeneick","year":"2005","journal-title":"Am Heart J"},{"key":"R20-13-20210226","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2011.07.009","article-title":"Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome","volume":"164","author":"D\u2019Alto","year":"2013","journal-title":"Int J Cardiol"},{"key":"R21-13-20210226","first-page":"63","article-title":"Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease","volume":"64","author":"Vis","year":"2013","journal-title":"Int J Cardiol"},{"key":"R22-13-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.repc.2012.02.023","article-title":"Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease","volume":"32","author":"Baptista","year":"2013","journal-title":"Rev Port Cardiol"},{"key":"R23-13-20210226","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","article-title":"Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease","volume":"93","author":"Diller","year":"2007","journal-title":"Heart"},{"key":"R24-13-20210226","first-page":"1846","article-title":"Efficacy of oral bosentan for treatment of congenital heart disease-associated pulmonary arterial hypertension","volume":"34","author":"Ye","year":"2014","journal-title":"J Southern Med Univ"},{"key":"R25-13-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/chd.12147","article-title":"Acute hemodynamic effects of single oral dose of bosentan in patients with pulmonary arterial hypertension related to congenital heart disease","volume":"9","author":"Ajami","year":"2014","journal-title":"Congenit Heart Dis"},{"key":"R26-13-20210226","first-page":"2106","article-title":"Outcome of oral bosentan in children with congenital heart disease associated pulmonary arterial hypertension","volume":"89","author":"Xu","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R27-13-20210226","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00392-005-0266-6","article-title":"Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children","volume":"94","author":"Gilbert","year":"2005","journal-title":"Z Kardiol"},{"key":"R28-13-20210226","first-page":"31","article-title":"Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.","volume":"25-","author":"Sitbon","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R29-13-20210226","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.129.4.1009","article-title":"Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease","volume":"129","author":"Benza","year":"2006","journal-title":"Chest"},{"key":"R30-13-20210226","first-page":"256","article-title":"Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects]","volume":"35","author":"Mehta","year":"2008","journal-title":"Tex Heart Inst J"},{"key":"R31-13-20210226","first-page":"196","article-title":"A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease","volume":"91","author":"Durongpisitkul","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"R32-13-20210226","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1017\/S1047951116000056","article-title":"Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study","volume":"26","author":"Amedro","year":"2016","journal-title":"Cardiol Young"},{"key":"R33-13-20210226","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.amjcard.2011.07.006","article-title":"Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease","volume":"108","author":"Monfredi","year":"2011","journal-title":"Am J Cardiol"},{"key":"R34-13-20210226","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cardfail.2012.02.004","article-title":"Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome","volume":"18","author":"Kaya","year":"2012","journal-title":"J Card Fail"},{"key":"R35-13-20210226","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00138706","article-title":"Results of European post-marketing surveillance of bosentan in pulmonary hypertension","volume":"30","author":"Humbert","year":"2007","journal-title":"Eur Respir J"},{"key":"R36-13-20210226","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"R37-13-20210226","first-page":"638","article-title":"Safety and tolerability evaluation of oral bosentan in adult congenital heart disease associated pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"18","author":"Guo","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R38-13-20210226","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/hrt.2004.051961","article-title":"Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease","volume":"91","author":"Apostolopoulou","year":"2005","journal-title":"Heart"},{"key":"R39-13-20210226","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.healun.2015.12.016","article-title":"Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification","volume":"35","author":"Ramjug","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"R40-13-20210226","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1055\/s-0042-117784","article-title":"ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment","volume":"141","author":"Opitz","year":"2016","journal-title":"Deutsch Med Wochenschr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:59:09Z","timestamp":1620961149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201803090-00013"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010075","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}